Bain Capital Life Sciences Investors, LLC: holdings and changes

Number 58 of the top 100 funds by copy return. Bain Capital Life Sciences Investors, LLC reported 23 US stocks worth $1.5B for the quarter ending 2026-09-30 and changed 4 new, 2 added, 3 trimmed and 2 sold since 2026-06-30.

Copy return, 4 quarters+44.6%
US 500, same time+14.5%
Size$1.5B
Stocks23

Holdings

StockChangeWeightValueShares
KLRA
Kailera Therapeutics INC
17.29%$258M22,583,268
HTFL
Heartflow INC
TRIM -47%14.84%$221M4,448,158
ADRX
Adarx Pharmaceuticals INC
BUY9.00%$134M6,728,970
ALKS
Alkermes PLC
ADD +63%8.56%$128M3,150,985
NAMS
Newamsterdam Pharma Company
6.21%$93M3,806,559
SVRA
Savara INC
6.09%$91M17,600,621
TARS
Tarsus Pharmaceuticals INC
BUY5.78%$86M1,096,141
PHVS
Pharvaris N V
TRIM -7%5.26%$78M2,475,509
SLDB
Solid Biosciences INC
4.75%$71M9,808,819
OLEMA PHARMACE
Olema Pharmaceut
4.10%$61M7,085,249
COAG
Hemab Therapeutics Hldgs INC
3.41%$51M1,650,000
CABA
Cabaletta Bio INC
ADD +23%2.73%$41M21,209,188
FRNM
Freenome INC
BUY2.50%$37M2,365,459
DYN
Dyne Therapeutics INC
BUY2.05%$31M1,900,000
CCCC
C4 Therapeutics INC
1.60%$24M7,171,910
XFOR
X4 Pharmaceuticals INC Com New
1.55%$23M7,967,454
ANNX
Annexon INC
1.26%$19M4,437,731
AVIR
Atea Pharmaceuticals INC
0.73%$11M2,075,639
IRON
Disc Medicine INC
0.62%$9M141,234
KYTX
Kyverna Thera INC
TRIM -55%0.60%$9M1,312,000
RPID
Rapid Micro Biosystems INC
0.58%$9M8,434,560
XLO
Xilio Therapeutics INC
0.40%$6M664,021
NAMS
Newamsterdam Pharma Company
0.08%$1M99,999
DNTH
Dianthus Therapeutics INC
SELL0%was $35M0
UPB
Upstream Bio INC
SELL0%was $4M0

Copy return each quarter

HeldFund copyUS 500
2023-09-30 → 2023-12-31+36.0%+11.2%
2023-12-31 → 2024-03-31+26.7%+10.0%
2024-03-31 → 2024-06-30-13.1%+4.0%
2024-06-30 → 2024-09-30+2.5%+5.4%
2024-09-30 → 2024-12-31+0.6%+2.1%
2024-12-31 → 2025-03-31-19.9%-4.6%
2025-03-31 → 2025-06-30+10.4%+10.5%
2025-06-30 → 2025-09-30+50.1%+7.8%
2025-09-30 → 2025-12-31+42.1%+2.4%
2025-12-31 → 2026-03-31-4.5%-4.6%
2026-03-31 → 2026-06-30+9.0%+14.8%
2026-06-30 → 2026-09-30-2.3%+2.1%

The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.

All top 100 funds, live

Other top funds

Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP